A Ganesan

Budget reaction from Mr. A Ganesan, Group Vice Chairman, Neuberg Diagnostics

New Delhi, February 01, 2022: Reduction of sur-charge  to 12% on Long Term capital Gains is welcome step. Unintentional errors…

2 years ago

Neuberg Diagnostics expands its Presence in India with inauguration of a new lab in Telangana

New Delhi, July 13, 2021: India's fourth largest pathology player, Neuberg Diagnostics Private Limited inaugurated a new state of the…

3 years ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420